The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer

Lung Cancer, 05/04/2012

The data demonstrate that Glasgow Prognostic Score assessment is predictive of the most important aspects of platinum–related toxicity and this may partly explain its associations with poor clinical outcome in patients with metastatic lung cancer.

Print Article Summary Cat 2 CME Report